Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook
  • twitter
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
    • Contact Us
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
    • Report a Problem
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
    • MIS Systems
    • Online Data Verification
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
Home > 2021 > December

Month: December 2021

Draft Guidelines On Good Pharmacovigilance Practices For Registration Holders for view Comments to be Submitted to National PV Center DRAP till 15th January, 2022

Murtaza Awan General December 29, 2021January 6, 2022Pharmacy Services

Guidelines On Good Pharmacovigilance Practices For Registration Holders

PDF File Download

User Guide For Online Import / Export Applications Software

Murtaza Awan Drugs, General December 28, 2021January 6, 2022QA & LT

User Guide For Online Import / Export Applications Software.

PDF FileDownload

Drug Product Recall: Dextrose 25% Infusion (Batch# A042C21) by M/s Otsuka Pakistan Ltd, Hub, Baluchistan

Murtaza Awan Recall Alerts December 28, 2021February 22, 2022QA & LT

CDL has declared Dextrose Infusion 25% (Batch # A042C21) as substandard, Manufactured By M/S. Otsuka Pakistan Ltd., Hub.

PDF FileDownload

Pre-Submission Screening Checklist for Biological Registration Dossier

Murtaza Awan Drugs December 22, 2021December 27, 2021Guidelines

Application shall be received for detailed evaluation if all the below mentioned documents are submitted.

PDF FileDownload

Holding Of E-Kachehri

Murtaza Awan News & Updates December 18, 2021December 29, 2021Other

As per directions of Prime Minister’s office for reaching out to public through Khuli E-Kacheri, CEO-DRAP has been pleased to schedule holding of 13th Khuli E-Kachehri through LIVE session on official Facebook page of DRAP (www.facebook.com/officialDRAP) on 22nd October-2021 (Friday) at 10:00 am to address public complaints relating to DRAP.

PDF FileDownload

Certificate Of Good Manufacturing Practices (GMP) For Establishment Units Manufacturing Medical Devices: Policy Board Decision.

Murtaza Awan Medical Devices December 17, 2021December 27, 2021Other

“The Board in order to ensure conformance to standards decided that validity of GMP certificate for local manufacturing will be one year for first three years for grant of Establishment License and thereafter validity will be for three years.

PDF File Download

Training: Implementation of online software for import export clearance

Yasir Mahmood General December 16, 2021December 27, 2021Other

Training announcement for software for import export clearance (therapeutic goods raw material).

PDF FileDownload

Minutes of 283rd Meeting of Central Licensing Board held on 28th October 2021

Asad Ullah Central Licensing Board December 13, 2021March 18, 2024
283rd meeting of CLB held on 28th October, 2021Download

Deficiency letter of all deferred products in 93rd meeting of EEC held on 11-08-2021

Yasir Mahmood Alternative Medicines December 13, 2021December 29, 2021Other

applicants were placed before the Enlistment Evaluation Committee (EEC) in its 93rd meeting held on 11th August, 2021 and the same have been deferred being deficient of the information / documents.

PDF FileDownload

Drug Product Recall: Practel Paediatric Oral Suspension (Batch# AA008) by M/s Health Care Pharmaceuticals, Multan

Murtaza Awan Recall Alerts December 8, 2021February 23, 2022QA & LT

Practel Paediatric Oral Suspension-Manufactured By M/S. Health Care Pharmaceuticals, Multan.

Practel
  • ← Previous

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • February 2018
  • November 2017
  • October 2017
  • July 2017
  • June 2017
  • May 2017
  • March 2017
  • November 2016
  • June 2016
  • March 2016
  • May 2014
  • March 2014
  • January 2014
  • October 2013
  • August 2013
  • April 2013
  • October 2012
  • July 2012
  • March 2012
  • February 2002

Meta

  • Log in

Quick Navigation

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem